Epidemiology of neonatal early-onset sepsis in a geographically diverse Australian health district 2006-2016 by Braye, K et al.
RESEARCH ARTICLE
Epidemiology of neonatal early-onset sepsis
in a geographically diverse Australian health
district 2006-2016
Kathryn BrayeID
1,2☯*, Maralyn Foureur1,2,3☯, Koert de Waal4,5‡, Mark Jones6‡, Elise Putt2☯,
John Ferguson2,5,7☯
1 Faculty of Health, University of Technology, Sydney, New South Wales, Australia, 2 Hunter New England
Health, Newcastle, New South Wales, Australia, 3 School of Nursing and Midwifery, University of Newcastle,
Newcastle, New South Wales, Australia, 4 Department of Neonatology, John Hunter Hospital, Newcastle,
New South Wales, Australia, 5 School of Biomedical Sciences and Pharmacy, University of Newcastle,
Newcastle, New South Wales, Australia, 6 Hunter Medical Research Institute, Newcastle, New South Wales,
Australia, 7 New South Wales Health Pathology, Newcastle, New South Wales, Australia
☯ These authors contributed equally to this work.




To describe the epidemiology of EOS including blood culture utilisation, across a large and
geographically diverse Australian health district.
Background
Sepsis in the first three days of life remains a leading cause of death and morbidity. In high-
income countries, group B Streptococcus (GBS) and Escherichia coli (E. coli) have domi-
nated as causes of EOS for five decades.
Method
An 11-year retrospective cohort study to determine the epidemiology of EOS. Incidence
rates were calculated per 1000 live births. Logistic regression with linear temporal trend and
covariates for potential effect modifiers were employed. Blood culture utilisation was deter-
mined by examining the rate of babies undergoing blood culture within 72 hours of birth.
Results
Among 93,584 live born babies, 65 had confirmed EOS (0.69/1000 live births); 22 term, 43
preterm. Across the 4 largest birth units, the proportion of babies having blood cul-
ture within 72 hours of birth varied from 1.9–5.1% for term and 21–35% for preterm
babies. The annual change in the EOS rate was significant, OR 0.91 (95% CI, 0.84 to 0.99,
p = 0.03). Group B Streptococcus was the most common cause of EOS in term neonates at
0.35/1000 live births (95% CI, 0.07–0.63) in 2006 and 0.1/1000 live births (95% CI, 0–0.2) in
2016. Escherichia coli was the most common cause in preterm babies at 3.4/1000 (95% CI,







Citation: Braye K, Foureur M, de Waal K, Jones M,
Putt E, Ferguson J (2019) Epidemiology of
neonatal early-onset sepsis in a geographically
diverse Australian health district 2006-2016. PLoS
ONE 14(4): e0214298. https://doi.org/10.1371/
journal.pone.0214298
Editor: Christine E. East, Monash University,
AUSTRALIA
Received: November 13, 2018
Accepted: March 11, 2019
Published: April 8, 2019
Copyright: © 2019 Braye et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: The data underlying
the results presented in this study is publicly




Funding: The author(s) received no specific
funding for this work.
Competing interests: The authors have declared
that no competing interests exist.
0.11–6.76) in 2006 reducing significantly to 1.35/1000 live births (95% CI, -0.07–2.78) by
2016.
Conclusions
Escherichia coli and GBS were the most common causes of EOS in preterm and term
babies respectively. Rates of all cause term and preterm EOS declined significantly as did
preterm sepsis due to E. coli. While rate of sepsis due to early-onset GBS declined, this did
not reach significance. Given the high proportion of preterm babies undergoing blood cul-
ture, it is unlikely that any EOS events were missed.
Introduction and Background
Neonatal EOS refers to culture-proven bloodstream and/or central nervous system infection
occurring in live born neonates soon after birth. It remains a significant cause of infant mor-
bidity and mortality in both high and low-income countries [1]. Most events occur in the first
48 hours of life [2]. Based on varying definitions, recent reported estimated incidences of cul-
ture proven EOS range from 0.01 to 0.53/1000 live births in Europe [3], 0.77/1000 in the USA
[4, 5] to 0.83/1000 in Australia [6]. Recorded mortality has been as high as 30% in high-income
and 60% in low-income countries[3] but has reduced in high income jurisdictions in recent
years to around 10% of all babies with EOS [3, 7]. Preterm babies continue to suffer a much
higher mortality than term infants [8]. Neonatal EOS is almost always due to pathogenic
microorganisms acquired from the mother, either during or preceding birth [2, 5]. Infection
may be trans-placental (haematogenous) but is more commonly thought to occur by an
ascending route from the mother’s genitourinary tract [9].
Risk factors for early-onset sepsis
Perinatal maternal risk factors reported to be associated with EOS include recto-vaginal GBS
colonisation, rupture of membranes (ROM)�18 hours, prematurity, and intrapartum fever
[3]. Recently authors have questioned the value of including fever as a surrogate for chorioam-
nionitis[10]. However currently, maternal fever (�38˚) remains a risk factor for EOS in most
jurisdictions [8, 11–13]. Other risk factors include bacteriuria in the index pregnancy and hav-
ing a previous child diagnosed with early-onset group B streptococcal infection (EOGBS) [11].
Pathogens
Early-onset sepsis due to E. coli is associated with high rates of mortality and morbidity, espe-
cially in preterm newborns [5]. The rate of multiple resistant E. coli has been described as sta-
ble overall but increasing in very low birth weight neonates (<1.500g) [14]. In term babies,
population-based neonatal infection surveillance studies demonstrate that GBS remains the
pathogen most frequently associated with term EOS [6, 15–17].
Early-onset group B streptococcal sepsis
Whilst there is a decline in early-onset GBS (EOGBS) sepsis whenever any maternal intrapar-
tum antibiotic prophylactic (IAP) is provided [18] and others have noted evidence for IAP to
be strong [6, 19], the most recent Cochrane review on the effectiveness of IAP concludes that
whilst IAP appeared to reduce EOGBS, this may be due to bias. The Cochrane reviewers found
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a high risk of bias for one or more key domains in the methodology and execution of the stud-
ies included in their analysis [20]. Therefore, Cochrane states there is a lack of evidence from
well designed and conducted trials to recommend IAP to reduce neonatal EOGBS. More
recently we undertook a broader, integrative review and concluded the evidence that the inci-
dence of EOGBS can be reduced by widespread administration of maternal IAP is not robust
[20].
Aim
To describe the epidemiology of EOS including blood culture utilisation, across a large and
geographically diverse Australian health district.
Materials and methods
A retrospective cohort study design was employed using data from a cohort of live born babies
and their mothers birthing in the Hunter New England local health district (HNELHD) in
New South Wales (NSW), Australia over the period 2006–2016.
Study setting and population
New South Wales is the largest and most populous state in Australia covering a region of
131,785 square kilometres, equivalent to the size of England. In 2008 the state was divided into
15 local health districts (LHDs). The HNELHD is geographically and socially diverse. As of
2016, the health district had 873,741 residents. Aboriginal and Torres Strait Islander people
account for 4.0% (equating to 21% of NSW’s Indigenous population) and 19% of residents
were born overseas [21]. The health district spans 25 local government areas and is the only
regional health district in NSW with a metropolitan hospital and level three neonatal intensive
care unit (NICU), an along-side birth centre and a freestanding birth centre nearby. In total,
these centres support around 4000 births per year. The district also includes a mix of several
large regional hospitals providing care for 500 to 1500 births per year through to 11 rural units
servicing a small percentage of people located in more remote settings supporting <250 births
per year.
Our study population included women from the original Hunter area birthing in 2006 to
2007. From 2008 onwards when HNELHD was formed, the cohort of women increased to
include the 16 units mentioned above. The study population included women and babies of all
risk categories, birthing within all publicly funded maternity services in the HNELHD includ-
ing hospital, birth centre and planned births at home. From 2006 onwards women in the
Hunter area/HNELHD were offered universal screening for GBS risk.
In this paper the term “pregnancies” better describes the total cohort of women as one
woman could have been pregnant more than once during the study period, however, the term
“women” represents all women and each of her pregnancies resulting in a live birth(s) from
2006 to 2016.
Blood culture utilisation
To evaluate EOS surveillance intensity, data from 2013 to 2016 were analysed to determine the
proportion of babies from whom at least one blood culture was collected during the first 72
hours of life stratified by gestation (term or preterm).
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Demographics
Inclusion criteria comprised live born infants and their mothers, born in the Hunter area 2006
to 2007 and expanded to include the newly formed HNELHD between 1st January 2008 and
31st December 2016. Stillborn babies, duplicate entries and entries with inadequate data were
excluded Fig 1.
Information was obtained from medical records and the maternity ObstetriX database.
ObstetriX (changed to e. Maternity in 2017) is a state wide surveillance system providing
point-of-care data collection across antenatal, intrapartum, and immediate postnatal periods.
Clinicians contribute information soon after birth. Local health district data custodians main-
tain the database.
We collected demographic data for mothers and babies, antenatal and intrapartum risk fac-
tors for EOS together with the neonatal hospital course and short-term neonatal outcomes.
Maternal GBS colonisation, prematurity, and rupture of membranes (ROM)�18 hours, plus
maternal age (age is categorical including�20 years versus all others), were collected and used
in analysis. While history of maternal GBS bacteriuria and a previous child with EOGBS are
both GBS risk factors, considered in a decision to offer IAP, we were unable to obtain informa-
tion on either. Data on rates of fever were poorly transcribed into the database and therefore
were not included as a risk factor for sepsis in our analysis.
Microbiological cultures
Results of culture positive blood and cerebrospinal fluid (CSF) specimens were accessed from
the publicly funded pathology service provider (Auslab) and three of four private pathology
providers. Early-onset sepsis events were identified from laboratory data, when significant iso-
lates (bacteria or fungi) were obtained from blood culture and/or CSF collected within the first
72 hours of life. Cultures yielding�3 bacterial species or a potential contaminant e.g. coagu-
lase negative Staphylococci, as specified by Schrag and colleagues, 2016 were assumed to have
been contaminated and were therefore excluded [5].
Fig 1. Inclusions and exclusions.
https://doi.org/10.1371/journal.pone.0214298.g001
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Definition of early-onset sepsis
Researchers use a range of time frames to define EOS ranging from 48 hours to 7 days post
birth [11]. The definition used here is neonatal sepsis arising within 72 hours of birth in accord
with the definition used by the UK National institute for clinical care excellence (NICE) [3,
22].
Morbidity and mortality
Admission and short-term morbidity were reported as serious or not serious. Serious morbid-
ity was defined as the need for significant respiratory or circulatory support requiring neonatal
intensive care and/or encephalopathy or seizures. It was not possible to assess long-term mor-
bidity. Live status of each baby with an EOS event as of December 2017 was derived from the
HNELHD patient demographics system, which is linked to NSW death registration data.
Prevention of group B streptococcal sepsis
Between 2006 and 2008, starting with the metropolitan unit in HNELHD, a program of GBS
screening for women reaching�35 weeks’ gestation was commenced. Mothers with recto/vag-
inal GBS colonisation or certain other risk factors for EOGBS (as documented above) are
offered IAP in labour, or at rupture of membranes if this occurs first in order to reduce the
likelihood of EOGBS.
Ethics approval
The study was approved by the HNELHD Human research ethics committee (HREC) on 05/
05/2016 with variation applied for and granted 09/03/2018 16/05/18/5/5.05 SSA. LNRSSA/16/
HNE/225 and The University of Technology Sydney (HREC): No. 2014000115. This publica-
tion adheres to the provision of privacy and confidentiality of patient data and clinical infor-
mation, including NSW health records and information privacy act, 2002. The purpose of our
study was to describe the epidemiology of EOS rather than individual events; therefore consent
from individuals was not required. All data was de-identified and password protected.
Statistical analysis
Descriptive statistics on sample characteristics are provided. Incidence rates were calculated as
cases per 1000 live births per year with t-tests being used for continuous variables. Chi-squared
tests were used for proportions and Wilcoxon rank sum tests for comparisons of medians. P-
values>0.05 suggest a statistically detectable difference between groups, which may or may
not be clinically relevant and/or meaningful. We explored temporal trends in background all-
cause EOS sepsis in the individual birth data by using logistic regression with a linear temporal
trend and covariates for potential effect modifiers.
Potential effect modifiers used were positive maternal GBS recto-vaginal colonisation, pre-
maturity (<37 weeks gestation), rupture of membranes (ROM)�18 hours and maternal age
(<20 years versus all others). We provide estimates of odds ratios, graphical visualisation,
probabilities of events and the associated 95% confidence intervals and p-values. All models
were checked for calibration and discrimination and we use a conventional significance level
of 0.05 throughout.
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Results
Study population
After exclusions, the study population included 62,281 women who had 92,055 pregnancies.
These women gave birth to 93,584 babies. There was an increase in the birthing population
during and after 2008 as the area restructured and HNELHD was formed. Ninety-eight per
cent of live born babies (90,510) were singletons and 8,165 (8.9%) of the pregnancies were pre-
term resulting in 9,146 (9.8%) preterm live born babies. Eight per cent of women (9,336) iden-
tified as Aboriginal or Torres Strait Islander (ASTI).
Table 1 provides a descriptive statistical summary of the data. It reports various characteris-
tics of our sample overall, stratified by EOS and No EOS. The p-values correspond to statistical
comparisons between the No EOS and EOS strata. Table 1 suggests statistically significant dif-
ferences between the No EOS and EOS groups for term versus preterm babies, type of preg-
nancy (singleton or other), ATSI mothers, rupture of membranes >18 hours and pregnancies
with positive maternal GBS colonisation. These variables with the exception of the type of
pregnancy (singleton versus other) and mothers that are ATSI are recognised risk factors for
EOGBS Table 1A & 1B. These results suggest that risk factors for EOS appear in our sample.
Early-onset sepsis
In total, 65 culture-proven EOS events were identified Fig 2. Over 80% of EOS was evident
within 48 hours of birth 82, and 88% for term and preterm groups respectively. Most, but not
all, babies subsequently diagnosed with EOS were born at the metropolitan unit 50/65 (77%).
The annual change in the background rate of all-cause EOS was significant at the 0.05 level
with a multiplicative change in the odds of EOS reducing by approximately 9% per year over
the study period as indicated by an odds ratio of 0.91 (95% CI, 0.84 to 0.99, p = 0.03). Six
women who identified as ATSI mothers had babies with EOS Table 1A & 1B.
Term babies with early-onset sepsis. Twenty-two, (34%) of the 65 babies with EOS were
term gestation. Baseline (2006) incidence of EOS in term infants was estimated with adjust-
ment for gestation, birth weight, maternal GBS carriage, ROM�18 hours and maternal age to
be approximately 0.5 (95% CI, 0.02 to 0.97)/1000 live births. By 2016, the rate was 0.19 (95%
CI, 0 to 0.4).
Preterm babies with early-onset sepsis. Forty-three babies who developed EOS were pre-
term. Baseline incidence of preterm EOS was estimated with adjustment for gestation, birth
weight, maternal GBS colonisation, ROM�18 hours and maternal age to be approximately
22/1000 live births (95% CI, 1.3 to 42.7) in babies with gestations <30 weeks and 3.4/1000 live
births (95% CI, 0.1 to 6.8) in babies with gestations 30 to 36 weeks and 6 days. By 2016, the
respective rates had fallen significantly to 8.8/1000 live births <30 weeks (95% CI, -0.5 to 18)
and 1.4/1000 live births between 30 and 36 and 6 days (95% CI, -0.1 to 2.8) Fig 3.
EOS surveillance intensity 2013–2016
Across the 4 largest birth units, the proportion of babies having at least one blood culture
within 72 hours of birth varied from 1.9 to 5.1% for term and 21 to 35% for preterm babies
with large year-to-year variation. Across the smaller units that do not care for preterm babies,
the proportion of babies cultured was 1.1% or less, with a mean of 0.7%.
Diagnosis
All EOS events were diagnosed by blood culture. Forty-one (63%) babies also underwent lum-
bar puncture; 11/41 (27%) term and 30/41 (73%) preterm. Lumbar punctures were taken
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within two days of a positive blood culture in 31/41 (76%) cases. Of the 41 lumbar puncture
tests taken, four (10%) were positive and results were in accord with the blood culture.
Gram-negative species predominated significantly in preterm EOS events, 24/43 (55%) and
(4/23) 17% in term babies (p = 0.006); E. coli and other Enterobacteriaceae were the leading
causes in 20/43 (45%) of the preterm cohort Table 2. The rate of EOS due to E. coli over the
study period was 0.19/1000 live births (n = 18); 0.02/1000 live births (n = 2) in the term cohort
and 1.75/1000 live births (n = 16) in the preterm cohort.
Table 1. 1a & 1b. Sample characteristics of women, their pregnancies, and babies.
Table 1a. Women Value Overall (%) No EOS (%) EOS (%) P value
Number of pregnancies 92055 91990 (99.9) 65 (0.1)
Type of pregnancy Singleton 90510 (98) 90453 (98) 57 (88) <0.001
Multiple 1545 (2) 1537 (2) 8 (12.3)
Term pregnancy (%) Term 83890 (91) 83868 (91) 22 (34) <0.001
Preterm 8165 (9) 8122 (9) 43 (66)
Median maternal age [IQR] 28 [24 to 32] 28 [24 to 32] 28 [24 to 32] 0.682
Aboriginal/Torres Strait Islander Yes 9336 (10) 9330 (10) 6 (9) <0.001
No 82590 (90) 82533 (90) 57 (88)
Not stated 103 (0.1) 103 (0.1) 0 (0)
Missing 26 (0) 24 (0) 2 (3)
Rupture of membranes� = 18 Yes 8881 (10) 8847 (10) 34 (52) <0.001
No 83129 (90) 83100 (90) 29 (45)
Missing 45 (0) 43 (0) 2 (0)
GBS result (total pregnancies) Positive 13288 (14) 13278 (14) 10 (15) 0.028
Negative 48236 (53) 48212 (52) 24 (37)
Unknown 30531 (33) 30500 (33) 31 (48)
Alcohol consumption 1 to < 5 2416 (3) 2415 (3) 1 (1.5) 0.002
1+daily 236 (0.3) 236 (0.3) 0 (0)
5+daily 216 (0.2) 216 (0.2) 0 (0)
None 88406 (96) 88344 (96) 62 (95)
Unknown 522 (0.6) 522 (0.6) 0 (0)
Missing 259 (0.3) 257 (0.3) 2 (3)
Smoking at booking Yes 19143 (21) 19130 (21) 13 (20) <0.001
No 72469 (79) 72419 (79) 50 (77)
Unknown 184 (0.2) 184 (0.2) 0 (0)
Missing 17 (0) 17 (0) 0 (0)
Prior pregnancy Yes 66648 (72) 66606 (72) 42 (65) 0.369
No 25390 (28) 25367 (28) 23 (35)
Missing 17 (0) 17 (0) 0 (0)
Table 1b. Babies
All babies 93584 93519 (99.9) 65 (0.1)
Singleton Yes 90510 (97) 90453 (97) 57 (88)
Term Yes 84438 (90) 84416 (90) 22 (34) <0.001
No 9146 (10) 9103 (10) 43 (66)
Mean birth weight (SD) 3360 (641) 3360 (640) 2217 (1135) <0.001
Median gestational age [IQR]) 40 [38, 41] 40 [38, 41] 33 [29, 39] <0.001
Legend: EOS = early-onset sepsis, [IQR] = interquartile range, ASTI = Aboriginal or Torres Strait Islander
1 to <5- = one drink daily and not more than 5 at one sitting, eligible = a pregnancy� 35 weeks gestation, ROM = rupture of membranes, GBS = group B streptococcus
https://doi.org/10.1371/journal.pone.0214298.t001
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Gram-positive species were responsible for most EOS cases in term babies 18/22 (82%) ver-
sus 18/43 (42%) in preterm babies Table 2. Group B Streptococcus constituted almost half of
EOS events in term babies at 10/22 (45%). The overall rate of EOGBS was 0.19/1000 (n = 18)
live births.
Neonatal clinical course
Of the 14 babies born outside the metropolitan unit, the majority 11/14 (79%) remained in
their regional unit of birth for on-going care. Two babies were transferred to the local metro-
politan unit and one was transferred out of the LHD. We were unable to follow up babies
transferred out of area, excluding mortality. Most babies with EOS are referred to one of the
public facilities for management and would have been captured within our data set. Further-
more, given the high proportion of preterm babies undergoing blood culture in our district
(21 to 35%), it is unlikely events were missed.
Fig 2. Early-onset sepsis events per 1000 live births.
https://doi.org/10.1371/journal.pone.0214298.g002
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All of the 65 babies were transferred to a neonatal intensive care unit/ special care unit
(NICU) but only 14/65 (22%) were admitted with a primary presumptive diagnosis of sepsis.
Other common reasons for admission were prematurity and/or respiratory distress.
All babies (except one unknown) subsequently diagnosed with EOS received antibiotics.
Empiric treatment was reported as intravenous penicillin and gentamicin in 61/64 cases
(95%). Term infants remained on antimicrobials for a median of seven days [IQR, 7.5, 5.0 to
12.5], and remained in hospital (NICU and/or ward) for a median of 7.5 days [IQR, 7.5, 3.5 to
Fig 3. Early-onset sepsis events by gestation.
https://doi.org/10.1371/journal.pone.0214298.g003
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11.0]. Forty-one (95%) preterm babies were known to have antibiotics. Preterm babies with
EOS also remained on antimicrobials for a median of seven days [IQR, 13.0, 3.3 to 16.3] and
remained in hospital for a median of 19 days [IQR, 34.0, 3.8 to 37.85].
Morbidity and mortality
Thirty-three (50%) babies had serious short-term morbidity, in particular, ventilatory support
requiring neonatal intensive care. Serious, short-term morbidity occurred in 8/13 (62%) term
babies with non-EOGBS sepsis and 4/10 (40%) term babies with EOGBS. It was not possible to
report on long-term morbidity.
Overall, 10/65 (17%) babies with EOS died; all were preterm. The rate of preterm mortality
was 1.1/1000 preterm births and rate of mortality per total live births was 0.1/1000. Gestation
ranged from 24 to 34 weeks and weight from 630 to 2440 grams. Six of the 10 babies that died
had early-onset E. coli infection. Mortality occurred at a median of three days after birth
[range 6 hours to 44 days]. All deaths occurred at the metropolitan hospital.
Discussion
This study provides an eleven-year, “real world” view of the epidemiology of EOS in a geo-
graphically and socially diverse setting. The EOS surveillance intensity varied with up to a two-
fold difference in the proportion of term babies undergoing blood culture testing across the
four largest neonatal units. Aside from the variation caused by different case mix, there are
likely to be significant differences in clinician thresholds for blood culture collection, which
Table 2. Term and preterm early-onset sepsis by organism.
Fungi Term Preterm Total
Candida glabrata 1 1
Gram negative bacteria
Acinetobacter baumannii complex 1 1
Escherichia coli� 2 16 18
Haemophilus influenzae 4 4
Klebsiella pneumoniae� 1 1
Morganella morganii� 1 1
Pseudomonas aeruginosa 1 1
Salmonella species� 1 1
Serratia marcescens� 1 1
Gram positive bacteria
Enterococcus faecalis 2 2
Enterococcus faecium 1 1
Streptococcus agalactiae (GBS) 10 8 18
Streptococcus pneumoniae 2 4 6
Streptococcus species (other) 2 4 6
Staphylococcus aureus (methicillin-susceptible) 1 2 3
Total 22 43 65
�These species are from the Enterobacteriaceae family.
No events due to methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci were detected. Of
the events due to E. coli, 67% were ampicillin resistant. No Gram-negative isolates producing extended spectrum
betalactamases or carbapenemases were detected
https://doi.org/10.1371/journal.pone.0214298.t002
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will impact on measured culture proven EOS rates. Blood culture utilisation should be
included in future studies in accord with best epidemiological practice.
All-cause EOS events declined significantly with a multiplicative change in the odds of EOS
reducing by approximately 9% per year over the study period. Escherichia coli (n = 18) and
GBS (n = 18) were the most common bacteria causing EOS events. The very low frequency of
EOS events limited what could be established statistically, however, the modelling showed a
significant reduction in E. coli but no evidence of a significant change in EOGBS over time.
Historically, babies of ATSI mothers have been over-represented in early-onset sepsis data.
In our study, there were six babies whose mothers were identified as ATSI. These babies repre-
sent 9% of all infants with EOS. This finding is similar to the proportion of ATSI women in
our total cohort Table 1A & 1B and agrees with Singh et al whose work suggests the rate of
EOS in babies of ATSI mothers may be decreasing [5].
The estimated incidence in 2016 of all-cause EOS in term babies was 0.19/1000 live births
(95% CI, 0 to 0.4) at the overall median birth weight of 3.42 kg. After adjustment was made for
gestation, birth weight, positive maternal GBS, ROM�18 hours and maternal age, this repre-
sented a non-significant decline from 0.5/1000 live births (95% CI, 0.02 to 0.97) in 2006 Fig 2.
This result is consistent with other studies [5, 6].
As expected, EOS was highest in preterm infants with two-thirds of events occurring in this
group. All-cause EOS events in preterm babies showed a significant decline over the years.
Adjusted rates were 3.4/1000 live births in 2006 (95% CI, 0.11 to 6.76) to 1.35/1000 live births
in 2016 (95% CI,-0.7 to 2.78). The most dramatic reduction occurred in babies<30 weeks ges-
tation. After adjustment, rates in this group fell from 22/1000 live births (95% CI, 1.3 to 42.7)
in 2006 to 8.8/ 1000 (95% CI, -0.5 to 18) in 2016. Preterm events that occurred from 2014–
2016 were confined to babies of gestation <30 weeks Fig 2.
The decline in incidence of all preterm EOS events possibly represents the effect of local
changes in the management of preterm birth which, since 2011, has included routine pre-emp-
tive antibiotic treatment upon presentation of mothers in preterm, or suspected preterm
labour (Murray, H., personal communication, 2018) and advances in neonatal intensive care
provision over the study period.
A universal screening approach was recommended in our LHD across the study years, with
risk factors considered if a woman was GBS unknown. The crude incidence of EOGBS across
term and preterm groups in our study was low at 0.19/1000 live births and, despite minor fluc-
tuations, did not change significantly over time. Whilst we acknowledge that EOGBS rates
have increased and decreased across various jurisdictions during our study period, our results
compare favourably with the contemporary incidence of EOGBS recorded by the English Neo-
natal Infection Surveillance unit, 0.57/1000 live births, using a risk factor approach [23]; a
large, multi-centre study from the US, 0.2/1000 live births, using a universal screening
approach [5] and 0.33/1000 live births in a recently published Australasian study [17]. In Aus-
tralia either a universal or risk factor approach is used. New Zealand recommends a risk-based
approach [24]
The use of IAP in our cohort has not been associated with a detectable increase in antimi-
crobial resistance or EOS due to non-GBS causes. However, increasing community colonisa-
tion with extended spectrum betalactamase-producing E. coli (7.5% in 2015) is documented in
Australia and may, in future lead to increasing EOS events due to such strains [25] Table 2. In
the tertiary facility, there have been two multi-resistant E. coli EOS events subsequent to this
study’s time period with isolates that were both resistant to gentamicin. One isolate was also
resistant to ceftriaxone (CTX-M-1 extended spectrum betalactamase gene detected).
Limitations of this study include the focus on reported culture-proven EOS events, which
may have under-estimated the true burden of EOS due to false negative culture results. While
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our models adjusted for relevant variables, we were unable to use all EOS risk factors, as his-
tory of GBS bacteriuria and having a previous child with EOGBS were not available from the
database. Fever is currently stated as a risk factor for EOS but was poorly documented and
therefore not used in our analysis.
The observational design may limit generalisability and is unable to rule out all possible
biases. Our study is however, generalisable to other diverse jurisdictions that can link pathol-
ogy data with a maternity outcomes database such as ObstetriX or e. Maternity.
We believe strengths of this study are the inclusion of women with low and high-risk preg-
nancies across a geographically and socially diverse region, over a long period of time, in a set-
ting where maternal universal screening for GBS was in place throughout the study period.
Further, unique to our study, the inclusion, and evaluation of EOS surveillance intensity by
studying blood culture utilisation.
Future direction
Neonatal sepsis is an important issue in both low and high-income countries. At best, these
invasive infections separate mothers and babies and strongly impact on the health care budget.
At worst, invasive sepsis increases preterm birth, stillbirth, neonatal morbidity, and mortality.
Although rates of GBS, the most common bacteria affecting term babies, remained low
throughout our study, the potential for a vaccination to reduce risk of EOS due to GBS is
attractive. In a recent multi-centre trial, GBS CPS III-TT conjugate vaccine significantly
delayed maternal vaginal and rectal GBS serotype III colonisation [26].
However, a significant proportion of EOS occurs before a pregnancy is term and is due
mainly to non-GBS causes. Most preterm babies do not benefit from maternal third trimester
GBS screening and may not benefit from GBS vaccination. Whilst antenatal and intrapartum
vigilance for signs of sepsis is crucial, a more upstream prevention such as optimisation of
maternal factors that influence the neonatal and vaginal microbiome is worth consideration.
Finally, a tool that can assist clinicians in predicting the probability of EOS based on mater-
nal risk factors as well as the baby’s clinical presentation is being used in West Australia. Using
this tool, the risk of EOS can be calculated in a baby born�34 weeks gestation [27]. The inter-
active calculator produces the probability of EOS per 1000 births. As well as reducing the pro-
portion of newborns undergoing laboratory testing and receiving empirical antibiotic
treatment [28], clinical care algorithms can assist a family’s decision making around GBS
screening and IAP provision, thereby possibly reducing the number of women and babies
unnecessarily exposed to this intervention[29]. Such public health initiatives are best imple-
mented, guided and audited by a multi-disciplinary maternity and neonatal care team.
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